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ADCPrevious studies suggested that the apparent diffusion coefficient (ADC) value could help in
the differentiation and characterization of the benign and malignant renal masses.
However, there is still wide overlap in the ADC values between the benign and malignant
tumors.
Objectives: To retrospectively assess the usefulness of the diffusion weighted imaging
(DWI) for the characterization and differentiation between benign and malignant renal
masses.
Methods: A total of 87 renal and/or upper ureteric masses were included in our study. The
signal intensity of the lesions was assessed on both the DWI and ADC map and the ADC
value was calculated. t test, ANOVA test and Receiver operating characteristic (ROC) curve
analysis were performed.
Results: The ADC values of benign lesions were significantly higher than those of the
malignant masses [3.2 versus 1.3  103 mm2/s], Median, P < 0.0001.The sensitivity and
specificity of the DWI for the differentiation of benign and malignant masses were 98%
and 73% using an ADC cutoffvalue of 2.2. Clear cell renal cell carcinoma demonstrates
higher ADC value than non clear cell RCC.
Conclusion: DWI-MRI has a role in differentiation of benign and malignant renal masses
and the characterization of different malignant categories, subtypes and grades.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
Noninvasive methods including CT and MRI play a vital
role in the diagnosis and characterization of renal masses.The choice of treatment varies between reassurance of the
patient, radiological follow-up, ablative procedures, and
partial and radical nephrectomy [1].
The conventional CT and MRI sequences cannot easily
differentiate benign from malignant lesions in many cases.
Studies have shown that 16–33% of nephrectomies are per-
formed on benign lesions [1].
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gadolinium-enhanced sequences in patients at risk for
nephrogenic systemic fibrosis (NSF) [2].
Diffusion weighted imaging (DWI) is based on the
detection of the Brownian motion of free water molecules
in tissue, which has been shown to be inversely propor-
tional to cellular density [3].
DWI is widely used in brain imaging and has been
proved to be of great value [3]. The recent advancement
in MRI equipment allowed the application of the DWI in
abdominal imaging [3].
DWI provides qualitative and quantitative information
on tissue characterization without the need for gadolinium
administration [4].
Previous studies on the renal neoplasms suggested that
the apparent diffusion coefficient (ADC) value could help in
the differentiation and characterization of the benign and
malignant renal masses [4].
However to our knowledge, there is still wide overlap in
the ADC values between the benign and malignant renal
tumors [5].
There is no enough data on whether the apparent diffu-
sion coefficient (ADC) value of the diffusion weighted
imaging (DWI) can help in the characterization of the
RCC pathological subtypes and grades [6].
The aim of this study was to retrospectively assess the
usefulness of the diffusion weighted imaging (DWI) for
the differentiation between benign and malignant renal
masses, characterization of the different subtypes and
grades of RCC, as well as the characterization of the differ-
ent grades of TCC.2. Patients & methods
This retrospective research was approved by our insti-
tutional medical review board. Patients’ consent was
waived.2.1. Inclusion and exclusion criteria
163 consecutive patients (with 173 renal and/or upper
ureteric lesions) were initially included in our study. Most
of these patients underwent MRI, follow-up, and definitive
management, including biopsy or surgical excision for
renal neoplasms. We retrospectively reviewed the MRI
examinations and pathological results for these patients.
For our patients, MRI was performed prior to the biopsy
and before any tumor therapy was given.
We included only the cases that have final diagnosis
available on our database. As regards the presumed simple
or mildly complex cystic lesion (Bosniak I and II cate-
gories), we included the cases that have at least 2-years
follow-up imaging as confirmation of stability.
We excluded the lesions that were missing the defini-
tive imaging/clinical diagnosis or histopathological confir-
mation (n = 50), the lesions that did not have the diffusion
weighted MRI sequence (n = 32), and the lesions in which
the diffusion weighted MRI was not interpretable due to
poor quality and obvious artifact (n = 4).Finally, total of 79 patients with 87 lesions were
included in our study.2.2. MRI protocol
MRI was performed using a 1.5 T MRI unit (Signa
horizon LX echo speed, General Electric Medical Systems,
Milwaukee, USA) using phased array surface body coil.
The following sequences were provided with respira-
tory triggering: Axial spin echo (SE) T1-weighted imaging,
axial and coronal fast spin echo (FSE) T2 weighted imaging,
and axial or coronal in and out of phase.
The Diffusion weighted imaging (DWI) sequence was
done in both the coronal and axial planes. This sequence
was obtained by single-shot spin echo planar imaging
(SE-EPI) using the following parameters: TR/TE: 8000/74–
104 ms, slice thickness, 5 mm, interslice gap, 0 mm, FOV,
42–46 and matrix: 128/128. B factor of 0 and 800 s/mm2
was used to calculate the ADC value.
Using the spoiled gradient echo (SGE) sequence in the
axial and coronal planes, multiphase dynamic post
contrast-enhanced (DCE) MR imageswere obtained. Con-
trast enhanced MRI was not performed in 11 of our
patients; because of reduced GFR in 10 and pregnancy in
one patient.2.3. Image analysis
2.3.1. DWI and ADC tumor signal (qualitative assessment)
The signal intensity of each lesion was scored both in
the ADC and DWI images using a 3-point rating scale com-
pared with contralateral parenchyma where 1 = hyperin-
tense, 2 = hypointense and 3 = isointense or mixed signal.2.3.2. Quantitative assessment of the ADC map
The DWI images were transferred to an independent
workstation (General electric) for postprocessing, and the
ADC maps were reconstructed.
The mean ADCs (±standard deviations) of each lesion
were measured from the ADC maps with average sized cir-
cular ROIs placed as follows:
For homogenous solid tumors, we chose the largest
possible ROI.
For heterogenous solid lesions, more than one ROI were
placed and the average ADC value was calculated.
As regards the solid tumors containing cystic necro-
sis, 2 ROIs were placed: one in the solid part and a second
ROI in the cystic component. For the complex cystic
lesions, the ROI was placed in the solid nodule or in the
thick septations.
The ADC images were reviewed in correlation with the
T1, T2 and post contrast images if available. This helped
optimum ROI placement.2.3.3. Lymphadenopathy
In positive cases, the DWI and ADC images were
reviewed to assess the signal intensity and ADC values
for the enlarged LNs.
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The definitive diagnosis was made by histopathological
examination. For lesions demonstrating typical benign
radiological features, the benign nature was confirmed by
at least 2-year interval stability.
2.5. Statistical analysis
The data were collected, coded, processed and analyzed
using SPSS ver 16 (statistical package for social sciences).
Descriptive statistics (mean (M), standard deviation (SD),
frequencies and percentages) were calculated.
When the data were parametric the Student’s t-test was
used in comparison with two groups while ANOVA test
was used in the case of more than two groups examined.
Relationships between categorical and continuous vari-
ables were examined using the Mann–Whitney U-test for
two ordered categorical variables.
Receiver operating characteristic (ROC) curve analysis
was used to compare diagnostic capabilities.
3. Results
A total of 87 lesions in 79 patients with renal and/or
upper ureteric masses were finally enrolled in our study
(69 male patients with 76 lesions and 10 female patients
with 11 lesions). The age range in our cases was 3–
84 years. The median age was 63 years.
The final diagnosis was proved by pathological exami-
nation (biopsy or nephrectomy) in 73 lesions. Lesions
demonstrated typical radiological benign features such as
AML (n = 1), simple cyst (n = 10), and mildly complex cysts
(n = 3). The benign nature was confirmed by at least
2 years of interval stability.
3.1. Study groups
These lesions were subdivided into 3 categories based






Fig. 1. Pie representation of all les3.1.1. Group 1: Cystic renal parenchymal masses
This group includes 22 lesions (18 benign and 4 malig-
nant). These lesions were categorized according to the Bos-
niak classification as follows: Bosniak grade I (n = 10),
Bosniak II (n = 3), Bosniak IIF (n = 2), Bosniak III (n = 5)
and Bosniak IV (n = 2).
3.1.2. Group 2: Solid renal parenchymal masses
This group includes 34 lesions (5 benign and 29
malignant).
3.1.3. Group 3: Urothelial lesions
This group includes a total of 31 TCC lesions (calyceal
(n = 23), renal pelvis (n = 2) and upper ureteric (n = 6)
(Fig. 1 for all lesions in our study).
3.2. Diffusion weighted MRI
All the 87 lesions were clearly identified on the DWI
images. The quality of DW images was good in all patients
(Table 1 for the signal intensity of the different lesions on
the DWI and ADC.
Four of the malignant lesions had metastatic renal hilar
and/or paraaortic LNS that were clearly identified on the
DWI as bright lesions.
16 out of the 22 cystic lesions demonstrated low signal
intensity on the DWI images at b 800. Three out of the four
malignant cystic lesions demonstrated low signal intensity
on both the DWI and ADC images.
Among the 29 malignant solid parenchymal renal
lesions, 20 lesions demonstrated high signal intensity on
the DWI with corresponding low signal intensity on the
ADC map in keeping with reduced diffusion.
7 lesions demonstrated mixed signal intensity on both
the DWI and the ADC images, which is attributed to the
mixed components. 3 of these lesions with the mixed sig-
nal were clear cell renal cell carcinoma (CCRCC), 2 lesions
were unclassified RCC and one lesion was lymphoma.
All the urothelial lesions in our study (n = 31) were his-






Mucinous tubular and 
spindle cell carcinoma 
Cystic 
Transitional cell carcinoma 
ions included in our study.
Table 1
The signal intensity of the different lesions on the DWI (b800) and ADC images.
No Solid Cystic Urothelial
Signal intensity on the DWI
Bright 58 24 3 31
Low 19 3 16 0
Mixed 10 7 3 0
Signal intensity on the ADC
Bright 17 3 14 0
Low 60 24 5 31
Mixed 10 7 3 0
Table 2
ADC values of all renal lesions.
Lesion No ADC  103 mm2/s
(mean ± SD)




Oncocytoma 4 2.4 ± 0.4
RCC 24 1.3 ± 0.6
Lymphoma 3 1.2 ± 0.4
Mucinous tubular and spindle
cell carcinoma
1 0.9
Urothelial: transitional cell carcinoma 31 1.4 ± 0.3
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low signal intensity on the ADC image.3.2.1. Benign versus malignant
Among the 87 lesions in this study, the total number of
benign lesion was 23, while the total number of malignant
lesion was 64 (Table 2 for ADC values of all lesions in this
study).
The ADC values of benign lesions were significantly
higher than those of malignant masses [3.2 (0.3–3.7)
versus 1.3 (0.3–2.9)  103 mm2/s), Median (Min–Max)
respectively, P < 0.0001] (Fig. 2).
In our study, ROC analysis was done twice to differenti-
ate malignant from benign renal lesions. AML was
excluded from both ROC curves to improve the specificity.
The first ROC curve included all the solid and cystic
parenchymal and urothelial lesions. The sensitivity and
specificity were 98% and 73% respectively using ADC cutoff
value of 2.2 for the differentiation between malignant and
benign renal lesions (Fig. 3).
The second ROC curve included only the solid renal
parenchymal and urothelial lesions. The sensitivity and
specificity were 98% and 75% respectively using ADC cutoff
value of 2.18 (Fig. 4).3.3. Cystic renal masses
The ADC values for the benign cystic lesions were sig-
nificantly higher compared with the malignant cystic
lesions 3.35 (0.32–3.7)  103 versus 0.63 (0.46–0.92) 
103 mm2/s [Median (Min–Max)] respectively (Tables 3
and 4).The lesions of higher Bosniak categories demonstrated
lower ADC value and most of them were malignant in nat-
ure. In our study, the ADC values for Bosniak categories I, II,
IIF, III were 3.49 ± 0.16, 2.43 ± 1.15, 1.65 ± 0.49 and
0.50 ± 0.25  103 mm2/s respectively. However, in our
study, grade IV had a mean ADC value of 2.09 ± 1.85, and
the accuracy of this value is questionable due to the lim-
ited number of cases in this category.
3.3.1. Benign cystic lesions and cystic necrosis in malignant
renal masses
Among the solid malignant masses in our study, 7
lesions demonstrated cystic necrosis. We measured the
ADC value of that cystic part separate from the solid
component.
The ADC values for the cystic component were signifi-
cantly lower compared with the benign cystic lesions of
2.2 versus 3.35  103 mm2/s respectively (Table 5).
3.4. Solid renal parenchymal masses
The ADC values for the solid malignant renal parenchy-
mal masses were significantly lower compared with the
benign solid parenchymal masses after exclusion of the
AML.
3.4.1. Characterization of the RCC subtypes
The ADC values for the clear cell RCC (CCRCC) were sig-
nificantly higher than those of the papillary RCC [1.8 (0.8–
2.9) versus 0.9 (0.3–1.9), median (min–max)] respectively,
p = 0.008. There was no significant difference between the
remaining RCC subtypes (Table 6).
Due to small number of lesions in each of the RCC sub-
type, we combined the papillary, chromophobe and
unclassified RCC in one group as non clear cell RCC (non-
CCRCC) and re-compared it to the ADC values for the
CCRCC (Table 7).
The ADC value for the CCRCC was 1.8  103 versus
1.04  103 mm2/s [Median (Min–Max)] for the non-
CCRCC.
3.4.2. Characterization of the RCC grade
We calculated the ADC values for the different RCC
grades. Both solid RCC and cystic RCC were included in this
comparison.
The ADC values for grades I, II and III were 1.3 (0.3–
1.66), 1.2(0.8–2.97) and 0.9 (0.31–1.38)  103 mm2/s
respectively (Table 8).
Fig. 2. Box-and-whisker plots of benign and malignant renal lesions (excluding AML).
Fig. 3. ROC curve shows the performance of DWI for differentiating
benign from malignant solid and cystic renal neoplasm.
Fig. 4. ROC curves show performance of DWI for differentiating benign
from malignant solid parenchymal and upper urothelial renal lesions.
Table 3
The mean ADC values of the different categories of cystic renal masses.
Lesion type No Bosniak
category
ADC  103 mm2/s
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study were malignant of the transitional cell carcinoma
type. The mean ADC value for the TCC was
1.4 ± 0.3  103 mm2/s.Simple cyst 10 I 3.49 ± 0.16
Mildly complicated cyst 3 II 2.73 ± 0.64
Chronic abscess 3 III 0.33 ± 0.01
Hemorrhagic cyst 2 IIF 2.35 ± 1.48
Cystic renal carcinoma 4 III & IV 0.66 ± 0.234. Discussion
In our study, most of the solid malignant lesions
demonstrated bright signal on the DWI image with corre-
Table 4
The ADC values of benign and malignant cystic lesions.
Cystic,
parenchymal




Benign 18 3.35 (0.32–3.7) Z = 2.4
Malignant 4 0.63(0.46–0.92) P = 0.01
Table 5
Benign cystic lesions versus malignant cystic necrosis.




Benign cystic lesions 18 3.35 (0.32–3.7) Z = 2.06
Cystic necrosis 7 2.2 (0.5–3) P = 0.03⁄
P = 0.03⁄: statistically significant.
Table 6
The mean ADC values for the different RCC subtypes.
Lesion n = 24
No ADC  103 mm2/s Mean ± SD
RCC type
Clear cell 7 1.7 ± 0.7
Papillary 11 0.96 ± 0.5
Chromophobe 2 1.4 ± 0.4
Unclassified 4 1.2 ± 0.4
Table 7
The ADC values for the CCRCC and Non CCRCC.
Lesion n = 24 Test of
significanceADC  103 mm2/s median
(Min–Max)
RCC type
Non clear cell 1.04 (0.3–1.9) Z = 2.6
Clear cell 1.8 (0.8–2.9) P = 0.008⁄
P = 0.008⁄: statistically significant.
Table 8
The ADC values of the different RCC grades.
Lesion No ADC  103 mm2/s
RCC grade
I 5 1.3 (0.3–1.66)
II 15 1.2 (0.8–2.97)
III 8 0.9 (0.31–1.38)
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nal helped the identification of the lesion and determina-
tion of its extent.
Whereas, the majority of the benign masses demon-
strated low signal on the diffusion weighted images, most
of the benign lesions in this study were of cystic nature.
Some of the benign lesions demonstrated high signal on
the DWI but in most of these cases this was attributed to
the T2 shine through effect and these lesions showed high
signal on the ADC map as well.The ADC is a quantitative parameter that detects the
extent of diffusion of water molecules. It is computed from
DW-MRI [7].
Multiple b values are used in the clinical practice to
increase the accuracy of the ADC calculation. Many studies
suggested that using b value higher than 400 s/mm2 for
abdominal diffusion MRI scans gives more accurate ADC
measurement as it reduces the T2 shine through and intra-
voxel perfusion effect [8,9].
On the other hand, higher b values reduce the signal to
noise ratio and result in anatomic distortion [8,10,11].
Wu et al. found that a b-value of 1500 s/mm2
significantly improved the specificity, but not the sensitiv-
ity, in diagnosing upper urinary tract cancer compared to a
b-value of 500 s/mm2 S [11].
Bozcurt et al. found that a b-value of 800 s/mm2
increased specificity with no significant effect on sensitiv-
ity and accuracy compared to a b-value of 400 s/mm2 [12].
We used a b value of 800 s/mm2 as part of our standard
renal mass MRI protocol.
In general, we found that the ADC values for the cystic
lesions are higher than those of the solid lesions.
Simple cysts have the highest ADC value, because of
their high water content which allows unrestricted diffu-
sion [13]. The mean ADC value for simple renal cysts in
our study was 3.49 ± 0.16, which is close to a study by
Zhang et al. (3.269 ± 0.61  103 mm2/s) [14].
This is slightly higher than the result of Inci et al., who
reported mean ADC value of 3.09 ± 0.14  103 mm2/s in
Bosniak I category [15].
Similar to previous studies, the ADC values for the
benign cystic lesions in our study are significantly higher
compared with the malignant cystic lesions (Table 4).
In our study, the ADC values for the mildly complicated
(Bosniak II) and the hemorrhagic cysts are
2.73 ± 0.64  103 mm2/s and 2.35 ± 1.48  103 mm2/s
respectively. These results are in agreement with a study
by Zhang et al., which showed an ADC value of
2.6 ± 0.4  103 mm2/s for the hemorrhagic renal cysts
[14].
Similar to previous studies, we found that the ADC
value of renal abscess is low 0.33 ± 0.01  103 (Fig. 5).
We found that as the complexity of the renal cysts
increases (higher Bosniak categories), the ADC values
decrease as these lesions are more likely to be malignant
(Table 3).
In our study, grade IV had a mean ADC value of
2.09 ± 1.85, the accuracy of this value is questionable due
to the limited number of cases in this category.
In a study by Göya et al., the mean ADC value of Bosniak
Category I cysts was 2.93 ± 0.14  103 mm2/s in, which is
relatively lower than that in our study [13].
The mean ADC value for Bosniak Category II cysts in
that study by Goya et al., was 2.49 ± 0.30  1023 mm2/s,
and they found that the mean ADC value of Bosniak Cate-
gory III cysts was 1.95 ± 0.27  103 mm2/s [13].
We found that there is a significant difference between
grade I and grade II Bosniak categories (P = 0.01), between
grade I and III (P = 0.002) and also between grade II and III
(P = 0.02). These results are concordant with the study of
Goya et al. [13].
Fig. 5. Chronic abscess (confirmed surgically). (A and B) Non and post contrast axial CT images demonstrating a large peripherally enhancing complex mass
arising from and posteriorly displacing the right kidney. Hyperdense content is identified within the mass. (C) Axial T1 FSE. (D and E) Axial and coronal T2
FSE: The mass displays heterogenous signal on both T1 and T2 images with internal debris. (F) Axial post contrast SGRE: The mass demonstrates thick rim
peripheral enhancement. (G and H) DWI and ADC map in the coronal plane reveal reduced diffusion within the mass, and the ADC value is
0.32  103 mm2/s.
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Fig. 6. 51-year old female patient with a left renal mass. (A) Axial spin echo T1WI: The mass is hyperintense with signal intensity similar to the
subcutaneous and retroperitoneal fat. (B) Axial T2 FSE: The mass is predominantly hyperintense with few hypointense streaks. (C and D) Coronal in and out
of phase images: The mass is hyperintense on the in phase image (C) with no significant drop of its signal on the out of phase (D) image. Note the chemical
shift artifact at fat water interface (arrow in D). (E) Axial T1 Post contrast SPGR shows complete loss of the high signal of the mass which confirms the
presence of macroscopic fat. (F) DWI (b = 800 s/mm2): The mass is hypointense to the adjacent renal parenchyma, (G) ADC map: the ADC value of the lesion
was 0.56  103 mm2/s. The definitive imaging diagnosis was angiomyolipoma.
1696 D.M. Sobh et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1689–1700We did not find any significant statistical difference
between IIF and I, IIF and II, IIF and III or III and IV Bosniak
categories. The accuracy of these results needs to be
assessed by future studies including larger number of
cases.4.1. Cystic necrosis versus benign cysts
Zhang et al., found that the cystic necrosis, unlike
benign cyst, shows reduced diffusion and lower ADC values
even though they can both display similar appearance on
Fig. 7. Oncocytoma. (A) Axial T1WI. (B) Axial T2 WI. (C and D) Axial and coronal post contrast T1. The mass displays heterogenous signal with mild
enhancement and areas of central necrosis. (E and F) DWI and ADC map on the coronal plane: The mass demonstrates reduced diffusion with bright signal
on the DWI and low signal on the ADC map. The ADC value is 2  103 mm2/s.
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ure of the cystic necrosis, which is made of non-enhancing
nonviable tissue [14].
Our results are in agreement with the prior studies. The
ADC values for the malignant cystic component were sig-
nificantly lower compared with the benign cystic lesions
(Table 5).
Sevcenco et al., found no significant differences
between the ADC values of benign and malignant solid
renal lesions using 3T MRI. Benign cystic lesions were
excluded from Sevcenco et al.’s study [16].
However, a meta-analysis by Liu et al., found that the
ADC values of malignant renal lesions were markedly
lower than those of benign renal lesions [4].
Our results are in agreement with this meta-analysis. In
our study, the ADC values of the malignant lesions (solid
and cystic) were significantly lower than those of the
benign renal masses [1.3 (0.3–2.9) versus 3.2 (0.3–3.7) 103 mm2/s], Median (Min–Max) respectively, P < 0.0001
(Fig. 2).
A study by Doagany et al., which included both solid
and cystic renal parenchymal lesions (excluding AML)
showed cutoff values of 2.36 for b value of 600, and 2.27
for b value of 1000 to differentiate malignant from benign
renal lesions. For b values of 600, and 1000 s/mm2, the sen-
sitivity was 71% and 90%, and the specificity was 91% and
73% respectively [8].
Angiomyolipoma (AML) is a benign renal neoplasm
that is composed of variable amounts of fat, abnormal
blood vessels and muscles.
As demonstrated in many previous studies, the ADC
value of AML is low, particularly the fat rich ones, mimick-
ing malignant lesions. The ADC value of our AML case was
0.6  103 mm2/s, which is even significantly lower than
RCC. These results are similar to those of the previous stud-






Fig. 8. RCC (clear cell subtype). 59-year old male patient with a complex solid mass in the lower pole of the right kidney. (A and B) Axial T1 and T2 FSE at the
level of the exophytic mass (thick white arrow an (a & b)). Note the T2 hyperintense central necrosis (thin white arrow in b). (C and D) Coronal post contrast
SGRE: The solid part of the mass enhances heterogeneously with non enhancing central necrosis (thin white arrow in d). (E and F) DWI and ADC map in the
coronal plane: The ROI was placed in the solid part which demonstrates restricted diffusion and ADC value of 1.38  103 mm2/s. (G and H) A second ROI
was placed in the cystic necrosis which has ADC value of 2.1  103 mm2/s (higher than the solid part but lower than simple cysts).
1698 D.M. Sobh et al. / The Egyptian Journal of Radiology and Nuclear Medicine 47 (2016) 1689–1700The low ADC value of AML is attributed to its abundant
fat content. Inci et al., observed decreasing ADC values of
angiomyolipomas with inverse correlation of the fatty
content [15].Accurate diagnosis of AML can be made by reviewing
the conventional MR images. We should be aware
that the DW MR is misleading in this benign category
(Fig. 6).
Table 9
Comparison between the ADC values of the different grades of TCC.
Lesion No ADC  103 mm2/s Test of significance
TCC grade
I1 6 1.59 ± 0.19 One way ANOVA
II 15 1.36 ± 0.26 F = 3.4
III1 10 1.22 ± 0.32 P = 0.05
1 Significant difference (P = 0.03).
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ADC value for these lesions was 2.4 ± 0.4 mm2/s (Fig. 7).
This is slightly higher compared to a study by Zhang
et al., where the mean ADC value for oncocytoma was
2.16 ± 0.02  103 mm2/s [14].
In our study, renal cell carcinoma (RCC) had a low ADC
value 1.3 ± 0.6  103 mm2/s. This is similar to previous
studies. For example, in a study by Yu et al., the ADC value
of RCC was 1.381 ± 0.4  103 mm2/s [17].
RCC is classified into several subtypes based on the
histopathological appearance, clinical course and the pres-
ence of abnormal genetic patterns. These subtypes include
CCRCC, papillary, chromophobe and unclassified RCC [4]
(see Fig. 8).
CCRCC has a worse prognosis than chromophobe or
papillary RCC. It is important to differentiate the various
subtypes of RCC as these subtypes respond differently to
molecularly targeted therapies [17].
A study by Wang et al., showed that the sensitivity and
specificity were 95.9% and 94.4% respectively to differenti-
ate CCRCC from non-CCRCC by using DWI [18].
Yu et al. [17] concluded that there is a significant differ-
ence in the ADC value between the CCRCC and non-CCRCC
(P = 0.001), CCRCC and chromophobe RCC (P < 0.001), and
between CCRCC and papillary RCC (P = 0.002), respectively.
In our study, there was a significant difference between
the ADC values of the CCRCC and papillary RCC (Table 6).
As suggested in many studies, the low ADC values of
papillary RCC can be explained by the high cellularity
which restricts the Brownian motion of water molecules
within the tumor cells [16].
Unlike the previous studies, we found that there is no
significant statistical difference between the CCRCC and
the chromophobe or the unclassified RCC. This could be
attributed to the small sample size in the non-CCRCC group
in our study.
Similar to the previous studies, we found that there is a
significant difference between the 2 groups with the
CCRCC demonstrating higher ADC value compared with
the non-CCRCC.
Studies by Rosenkrantz et al., and another study by Yu,
et al. concluded that the ADC value of low grade RCC
(grades I and II) is significantly higher than that of high-
grade RCC (grades III and IV) [5,6].
We found that the ADC values were lower in most of
our cases with high-grade RCC compared with low-grade
lesions (Table 8).
The ADC value for grade III was the lowest. There was a
statistical significant difference between grades II and III (P
value = 0.04) but not between grades II and I. We did not
have any grade IV lesions in our study.
All urothelial tumors in our groups (n = 31) were of the
transitional cell carcinomas (TCC) type, which is the most
common renal pelvis cancer.
We found that the mean ADC value of TCC is
1.4 ± 0.3  103 mm2/s. This is slightly lower than the
results of Paudyal et al., who reported an ADC value of
1.61 ± 0.80  103 mm2/s for TCC [19].
A study by Paudyal et al., concluded that the ADC value
for the RCC was significantly higher compared with the
TCC. TCC is histologically composed of solid and denselypacked tumor cells with hypercellularity compared with
RCC. In addition, RCC is frequently associated with the
hemorrhage, necrosis and cystic parts. These may explain
the higher ADC value of the RCC [19].
We found that the ADC values for the RCC were higher
than TCC but the difference was not statistically
significant.
To the best of our knowledge, there is no clear data
about the value of DWI in differentiating the different
grades of TCC.
We found that the higher-grade TCC demonstrates
lower ADC values.
There was statistical difference between grades I and III.
Although The ADC values of most of the grade I lesions
were lower than those of grade II, the difference was not
statistically significant (Table 9).
Renal hilar and paraaortic LNs were identified in 5 of
the malignant lesions in our study. These nodes were
clearly identified by DWI as bright lesions and demon-
strated low ADC values. Due to the small sample size, no
statistical analysis could be performed for this group.
4.2. Study limitations
Our study has several potential limitations: first, the
overall small size of the studied lesions particularly the
small number of benign renal masses and second, the small
number of each of RCC histological subtypes and grades.
Despite the small sample size, we were able to demon-
strate significant difference between benign and malignant
lesions.
Third, we did not study the combined use of DWI, con-
trast enhanced MRI, and MRI perfusion for the characteri-
zation of the renal masses, which probably will show
higher sensitivities and specificities. Future studies can
help further assessment of this combination.5. Conclusion
Our study has shown that the DWI-MRI and the quanti-
tative ADC measurements have a role in the differentiation
of benign and malignant renal masses and the characteri-
zation of different malignant categories, subtypes and
grades.
However, due to the overlap of the ADC values between
certain renal lesions, the DWI should be used in correlation
with the conventional MRI sequences.Conflict of interest
We have no conflict of interest to declare.
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